Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.

What was recalled

Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06

Recalling firm: Lupin Pharmaceuticals Inc.
NDC code: 68180-659-06
Origin: MD, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-0100-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Rifampin recalls

See all

Class II · Moderate risk Terminated Mar 21, 2024

Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202…

Reason Subpotent Drug

Lupin Pharmaceuticals Inc. NDC 6818-0659-06 D-0437-2024

Class II · Moderate risk Terminated Jan 11, 2024

Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging…

Reason Failed Impurities/Degradation Specification.

Amerisource Health Services LLC D-0285-2024

Class II · Moderate risk Terminated Jan 5, 2024